Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,897 | 266 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $907.22 | 56 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $608.12 | 40 | $0 (2024) |
| Novo Nordisk Inc | $489.93 | 44 | $0 (2023) |
| PFIZER INC. | $252.66 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $192.55 | 14 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $157.94 | 11 | $0 (2024) |
| Eisai Inc. | $114.11 | 7 | $0 (2021) |
| Lilly USA, LLC | $113.39 | 8 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $91.19 | 5 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $83.76 | 7 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $501.87 | 30 | AstraZeneca Pharmaceuticals LP ($165.58) |
| 2023 | $625.07 | 37 | AbbVie Inc. ($310.49) |
| 2022 | $574.83 | 35 | ABBVIE INC. ($174.95) |
| 2021 | $775.93 | 50 | AbbVie Inc. ($283.10) |
| 2020 | $325.26 | 24 | Novo Nordisk Inc ($70.85) |
| 2019 | $274.64 | 19 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($74.99) |
| 2018 | $301.57 | 24 | Novo Nordisk Inc ($137.46) |
| 2017 | $517.75 | 47 | Novo Nordisk Inc ($127.47) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: PAIN | ||||||
| 08/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Inflammation | ||||||
| 08/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Respiratory | ||||||
| 07/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Respiratory | ||||||
| 05/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Inflammation | ||||||
| 05/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: RESPIRATORY | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Respiratory | ||||||
| 04/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Gastroenterology | ||||||
| 04/23/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: ANTIBIOTIC | ||||||
| 04/02/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: PAIN | ||||||
| 04/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), AIRSUPRA | Food and Beverage | In-kind items and services | $45.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/19/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,164 | 1,385 | $141,671 | $60,985 |
| 2022 | 10 | 1,224 | 1,496 | $156,978 | $68,772 |
| 2021 | 10 | 1,176 | 1,424 | $140,646 | $63,874 |
| 2020 | 11 | 1,101 | 1,339 | $110,348 | $47,554 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 217 | 217 | $45,570 | $26,587 | 58.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 75 | $24,600 | $8,388 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 146 | $23,944 | $7,936 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 103 | $24,102 | $7,412 | 30.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 216 | 216 | $7,560 | $3,724 | 49.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 207 | 278 | $4,170 | $2,335 | 56.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $4,500 | $2,277 | 50.6% |
| 87084 | Screening test for pathogenic organisms with colony count | Office | 2023 | 37 | 50 | $2,250 | $1,327 | 59.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 235 | 271 | $4,065 | $921.39 | 22.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $910.00 | $79.76 | 8.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 217 | 217 | $45,570 | $27,764 | 60.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 130 | $30,420 | $10,960 | 36.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 58 | 83 | $27,224 | $10,176 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 166 | $27,224 | $9,003 | 33.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 216 | 216 | $7,560 | $3,831 | 50.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 22 | 22 | $6,600 | $3,542 | 53.7% |
| 87084 | Screening test for pathogenic organisms with colony count | Office | 2022 | 36 | 55 | $2,475 | $1,471 | 59.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 237 | 284 | $4,260 | $975.70 | 22.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 212 | 307 | $4,605 | $909.30 | 19.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 16 | $1,040 | $139.71 | 13.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 208 | 208 | $43,680 | $27,163 | 62.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 134 | 209 | $33,824 | $11,497 | 34.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 87 | 112 | $25,818 | $9,695 | 37.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 33 | 45 | $14,624 | $6,396 | 43.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 205 | 205 | $7,175 | $3,706 | 51.7% |
About Dr. Kristofer Sandlund, MD
Dr. Kristofer Sandlund, MD is a Family Medicine healthcare provider based in Zanesville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407844749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kristofer Sandlund, MD has received a total of $3,897 in payments from pharmaceutical and medical device companies, with $501.87 received in 2024. These payments were reported across 266 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,897).
As a Medicare-enrolled provider, Sandlund has provided services to 4,665 Medicare beneficiaries, totaling 5,644 services with total Medicare billing of $241,185. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties General Practice
- Location Zanesville, OH
- Active Since 10/11/2005
- Last Updated 04/28/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407844749
Products in Payments
- UBRELVY (Drug) $565.48
- BREZTRI (Drug) $244.39
- NURTEC ODT (Drug) $241.40
- Ozempic (Drug) $218.61
- FARXIGA (Drug) $175.74
- QULIPTA (Drug) $169.15
- Victoza (Drug) $157.11
- XARELTO (Drug) $149.51
- XIFAXAN (Drug) $144.73
- AIRSUPRA (Drug) $89.20
- CHANTIX (Drug) $85.43
- Vascepa (Drug) $78.53
- Dayvigo (Drug) $73.95
- TRULICITY (Drug) $67.90
- SYNTHROID (Drug) $66.26
- FreeStyle Libre 2 (Device) $62.42
- VRAYLAR (Drug) $60.31
- VOQUEZNA (Drug) $53.98
- Synthroid (Drug) $48.33
- ELIQUIS (Drug) $47.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Zanesville
Shelly Dunmyer, M.d, M.D
Family Medicine — Payments: $15,314
Dr. Thomas Forrestal
Family Medicine — Payments: $14,733
Dr. Ronald Kalchik, Do, DO
Family Medicine — Payments: $10,489
Dr. Bradley Colman, Do, DO
Family Medicine — Payments: $8,075
Dr. Michael Zimmerer, Md, MD
Family Medicine — Payments: $3,852
Dr. Lisa Flarey, Do, DO
Family Medicine — Payments: $3,290